Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Invigor Medical vs DadVantage Men's Health

Two GLP-1 desks, one scoreboard. We put Invigor Medical and DadVantage Men's Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 9 · Grade B+

Invigor Medical

Visit Invigor Medical Full brief →
vs
No. 452 · Grade C

DadVantage Men's Health

Visit DadVantage Men's Health Full brief →

The verdict

Invigor Medical takes this head-to-head.

Invigor Medical scores 88 to 50 on our six-factor Brief Score — An established telehealth pharmacy with a broad metabolic and hormone catalog and a steady price line.

That doesn't make DadVantage Men's Health a bad call — it's best for readers who want florida men wanting glp-1 weight loss bundled with trt and concierge men's wellness care. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
87
40
Supply Reliability
88
65
Transparency
84
23
Access Breadth
82
42
Clinical Oversight
88
70
Track Record
90
69
Invigor MedicalBrief Score 88 · 50DadVantage Men's Health

Price, coverage & the tracker

Invigor MedicalDadVantage Men's Health
Brief Score88/100 (B+)50/100 (C)
Semaglutide$199/moNot disclosed
Tirzepatide$339/moNot disclosed
CoverageNot disclosed1 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Invigor Medical: Long-running operator; mid-market pricing unchanged this cycle.

DadVantage Men's Health: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.